Ownership history in MPM BioImpact LLC · 20 quarters on record
This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Cullinan Management, Inc. (CGEM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 7,648,268 | — | 0% | 9.06% | $79.2M | $10.35 |
| 2025 Q3 | UNCHANGED | 7,648,268 | — | 0% | 7.42% | $45.4M | $5.93 |
| 2025 Q2 | UNCHANGED | 7,648,268 | — | 0% | 9.98% | $57.6M | $7.53 |
| 2025 Q1 | UNCHANGED | 7,648,268 | — | 0% | 9.95% | $57.9M | $7.57 |
| 2024 Q4 | UNCHANGED | 7,648,268 | — | 0% | 13.23% | $93.2M | $12.18 |
| 2024 Q3 | UNCHANGED | 7,648,268 | — | 0% | 19.21% | $128.0M | $16.74 |
| 2024 Q2 | UNCHANGED | 7,648,268 | — | 0% | 20.73% | $133.4M | $17.44 |
| 2024 Q1 | UNCHANGED | 7,648,268 | — | 0% | 20.95% | $130.3M | $17.04 |
| 2023 Q4 | UNCHANGED | 7,648,268 | — | 0% | 18.23% | $77.9M | $10.19 |
| 2023 Q3 | UNCHANGED | 7,648,268 | — | 0% | 18.48% | $69.2M | $9.05 |
As of 2025 Q4 — sorted by position size